Email
Print
Patient Derived Xenograft/PDX Models Market - Forecast(2024 - 2030)
1. Patient Derived Xenograft/PDX Models Market - Overview
1.1 Definitions and Scope
2. Patient Derived Xenograft/PDX Models Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Patient Derived Xenograft/PDX Models Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Patient Derived Xenograft/PDX Models Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Patient Derived Xenograft/PDX Models Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Patient Derived Xenograft/PDX Models Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Patient Derived Xenograft/PDX Models Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Patient Derived Xenograft/PDX Models Market - By Type (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Mice Models
8.3 Rat Models
9. Patient Derived Xenograft/PDX Models Market - By Tumor Type (Market Size -$Million / $Billion)
11.2 Application Revenue and Trends by type of Application
11.3 Application Segment Analysis by Type
11.3.1 Preclinical Drug Development And Basic Cancer Research
11.3.2 Biomarker Analysis
12. Patient Derived Xenograft/PDX Models- By Geography (Market Size -$Million / $Billion)
12.1 Patient Derived Xenograft/PDX Models Market - North America Segment Research
12.2 North America Market Research (Million / $Billion)
12.2.1 Segment type Size and Market Size Analysis
12.2.2 Revenue and Trends
12.2.3 Application Revenue and Trends by type of Application
12.2.4 Company Revenue and Product Analysis
12.2.5 North America Product type and Application Market Size
12.2.5.1 U.S
12.2.5.2 Canada
12.2.5.3 Mexico
12.2.5.4 Rest of North America
12.3 Patient Derived Xenograft/PDX Models- South America Segment Research
12.4 South America Market Research (Market Size -$Million / $Billion)
12.4.1 Segment type Size and Market Size Analysis
12.4.2 Revenue and Trends
12.4.3 Application Revenue and Trends by type of Application
12.4.4 Company Revenue and Product Analysis
12.4.5 South America Product type and Application Market Size
12.4.5.1 Brazil
12.4.5.2 Venezuela
12.4.5.3 Argentina
12.4.5.4 Ecuador
12.4.5.5 Peru
12.4.5.6 Colombia
12.4.5.7 Costa Rica
12.4.5.8 Rest of South America
12.5 Patient Derived Xenograft/PDX Models- Europe Segment Research
12.6 Europe Market Research (Market Size -$Million / $Billion)
12.6.1 Segment type Size and Market Size Analysis
12.6.2 Revenue and Trends
12.6.3 Application Revenue and Trends by type of Application
12.6.4 Company Revenue and Product Analysis
12.6.5 Europe Segment Product type and Application Market Size
12.6.5.1 U.K
12.6.5.2 Germany
12.6.5.3 Italy
12.6.5.4 France
12.6.5.5 Netherlands
12.6.5.6 Belgium
12.6.5.7 Denmark
12.6.5.8 Spain
12.6.5.9 Rest of Europe
12.7 Patient Derived Xenograft/PDX Models - APAC Segment Research
12.8 APAC Market Research (Market Size -$Million / $Billion)
12.8.1 Segment type Size and Market Size Analysis
12.8.2 Revenue and Trends
12.8.3 Application Revenue and Trends by type of Application
12.8.4 Company Revenue and Product Analysis
12.8.5 APAC Segment - Product type and Application Market Size
12.8.5.1 China
12.8.5.2 Australia
12.8.5.3 Japan
12.8.5.4 South Korea
12.8.5.5 India
12.8.5.6 Taiwan
12.8.5.7 Malaysia
12.8.5.8 Hong kong
12.8.5.9 Rest of APAC
12.9 Patient Derived Xenograft/PDX Models - Middle East Segment and Africa Segment Research
12.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
12.10.1 Segment type Size and Market Size Analysis
12.10.2 Revenue and Trend Analysis
12.10.3 Application Revenue and Trends by type of Application
12.10.4 Company Revenue and Product Analysis
12.10.5 Middle East Segment Product type and Application Market Size
12.10.5.1 Israel
12.10.5.2 Saudi Arabia
12.10.5.3 UAE
12.10.6 Africa Segment Analysis
12.10.6.1 South Africa
12.10.6.2 Rest of Middle East & Africa
13. Patient Derived Xenograft/PDX Models Market - Entropy
13.1 New product launches
13.2 M&A s, collaborations, JVs and partnerships
14. Patient Derived Xenograft/PDX Models Market - Industry / Segment Competition landscape Premium
14.1 Market Share Analysis
14.1.1 Market Share by Country- Top companies
14.1.2 Market Share by Region- Top 10 companies
14.1.3 Market Share by type of Application - Top 10 companies
14.1.4 Market Share by type of Product / Product category- Top 10 companies
14.1.5 Market Share at global level - Top 10 companies
14.1.6 Best Practises for companies
15. Patient Derived Xenograft/PDX Models Market - Key Company List by Country Premium
16. Patient Derived Xenograft/PDX Models Market Company Analysis
16.1 Market Share, Company Revenue, Products, M&A, Developments
16.2 Champion Oncology, Inc
16.3 Charles River Laboratory International, Inc
16.4 Crown Bioscience Inc
16.5 Epo Berlin-Buch Gmbh
16.6 Hera Biolabs
16.7 Horizon Discovery Group Plc
16.8 Oncodesign
16.9 Pharmatest Service Ltd
16.10 The Jackson Laboratory
16.11 Urolead
16.12 Wuxi Apptec
16.13 Xentech
16.14 Company 13
16.15 Company 14 & More
17.1 Abbreviations
17.2 Sources
18. Patient Derived Xenograft/PDX Models Market - Methodology
18.1 Research Methodology
18.1.1 Company Expert Interviews
18.1.2 Industry Databases
18.1.3 Associations
18.1.4 Company News
18.1.5 Company Annual Reports
18.1.6 Application Trends
18.1.7 New Products and Product database
18.1.8 Company Transcripts
18.1.9 R&D Trends
18.1.10 Key Opinion Leaders Interviews
18.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Patient Derived Xenograft/PDX Models Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Patient Derived Xenograft/PDX Models Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Patient Derived Xenograft/PDX Models Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Patient Derived Xenograft/PDX Models Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Patient Derived Xenograft/PDX Models Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Patient Derived Xenograft/PDX Models Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Patient Derived Xenograft/PDX Models Market - By Type (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Mice Models
8.3 Rat Models
9. Patient Derived Xenograft/PDX Models Market - By Tumor Type (Market Size -$Million / $Billion)
9.1 Introduction
9.2 Gastrointestinal Tumor Models
9.3 Gynecological Tumor Models
9.4 Respiratory Tumor Models
9.5 Urological Tumor Models
9.6 Hematological Tumor Models
9.7 Other Tumor Models
9.2 Gastrointestinal Tumor Models
9.3 Gynecological Tumor Models
9.4 Respiratory Tumor Models
9.5 Urological Tumor Models
9.6 Hematological Tumor Models
9.7 Other Tumor Models
10. Patient Derived Xenograft/PDX Models Market - By End User (Market Size -$Million / $Billion)
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.3 Contract Research Organizations
10.4 Academic & Research Institutions
10.2 Pharmaceutical & Biotechnology Companies
10.3 Contract Research Organizations
10.4 Academic & Research Institutions
11. Patient Derived Xenograft/PDX Models - By Application (Market Size -$Million / $Billion)
11.1 Segment type Size and Market Share Analysis11.2 Application Revenue and Trends by type of Application
11.3 Application Segment Analysis by Type
11.3.1 Preclinical Drug Development And Basic Cancer Research
11.3.2 Biomarker Analysis
12. Patient Derived Xenograft/PDX Models- By Geography (Market Size -$Million / $Billion)
12.1 Patient Derived Xenograft/PDX Models Market - North America Segment Research
12.2 North America Market Research (Million / $Billion)
12.2.1 Segment type Size and Market Size Analysis
12.2.2 Revenue and Trends
12.2.3 Application Revenue and Trends by type of Application
12.2.4 Company Revenue and Product Analysis
12.2.5 North America Product type and Application Market Size
12.2.5.1 U.S
12.2.5.2 Canada
12.2.5.3 Mexico
12.2.5.4 Rest of North America
12.3 Patient Derived Xenograft/PDX Models- South America Segment Research
12.4 South America Market Research (Market Size -$Million / $Billion)
12.4.1 Segment type Size and Market Size Analysis
12.4.2 Revenue and Trends
12.4.3 Application Revenue and Trends by type of Application
12.4.4 Company Revenue and Product Analysis
12.4.5 South America Product type and Application Market Size
12.4.5.1 Brazil
12.4.5.2 Venezuela
12.4.5.3 Argentina
12.4.5.4 Ecuador
12.4.5.5 Peru
12.4.5.6 Colombia
12.4.5.7 Costa Rica
12.4.5.8 Rest of South America
12.5 Patient Derived Xenograft/PDX Models- Europe Segment Research
12.6 Europe Market Research (Market Size -$Million / $Billion)
12.6.1 Segment type Size and Market Size Analysis
12.6.2 Revenue and Trends
12.6.3 Application Revenue and Trends by type of Application
12.6.4 Company Revenue and Product Analysis
12.6.5 Europe Segment Product type and Application Market Size
12.6.5.1 U.K
12.6.5.2 Germany
12.6.5.3 Italy
12.6.5.4 France
12.6.5.5 Netherlands
12.6.5.6 Belgium
12.6.5.7 Denmark
12.6.5.8 Spain
12.6.5.9 Rest of Europe
12.7 Patient Derived Xenograft/PDX Models - APAC Segment Research
12.8 APAC Market Research (Market Size -$Million / $Billion)
12.8.1 Segment type Size and Market Size Analysis
12.8.2 Revenue and Trends
12.8.3 Application Revenue and Trends by type of Application
12.8.4 Company Revenue and Product Analysis
12.8.5 APAC Segment - Product type and Application Market Size
12.8.5.1 China
12.8.5.2 Australia
12.8.5.3 Japan
12.8.5.4 South Korea
12.8.5.5 India
12.8.5.6 Taiwan
12.8.5.7 Malaysia
12.8.5.8 Hong kong
12.8.5.9 Rest of APAC
12.9 Patient Derived Xenograft/PDX Models - Middle East Segment and Africa Segment Research
12.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
12.10.1 Segment type Size and Market Size Analysis
12.10.2 Revenue and Trend Analysis
12.10.3 Application Revenue and Trends by type of Application
12.10.4 Company Revenue and Product Analysis
12.10.5 Middle East Segment Product type and Application Market Size
12.10.5.1 Israel
12.10.5.2 Saudi Arabia
12.10.5.3 UAE
12.10.6 Africa Segment Analysis
12.10.6.1 South Africa
12.10.6.2 Rest of Middle East & Africa
13. Patient Derived Xenograft/PDX Models Market - Entropy
13.1 New product launches
13.2 M&A s, collaborations, JVs and partnerships
14. Patient Derived Xenograft/PDX Models Market - Industry / Segment Competition landscape Premium
14.1 Market Share Analysis
14.1.1 Market Share by Country- Top companies
14.1.2 Market Share by Region- Top 10 companies
14.1.3 Market Share by type of Application - Top 10 companies
14.1.4 Market Share by type of Product / Product category- Top 10 companies
14.1.5 Market Share at global level - Top 10 companies
14.1.6 Best Practises for companies
15. Patient Derived Xenograft/PDX Models Market - Key Company List by Country Premium
16. Patient Derived Xenograft/PDX Models Market Company Analysis
16.1 Market Share, Company Revenue, Products, M&A, Developments
16.2 Champion Oncology, Inc
16.3 Charles River Laboratory International, Inc
16.4 Crown Bioscience Inc
16.5 Epo Berlin-Buch Gmbh
16.6 Hera Biolabs
16.7 Horizon Discovery Group Plc
16.8 Oncodesign
16.9 Pharmatest Service Ltd
16.10 The Jackson Laboratory
16.11 Urolead
16.12 Wuxi Apptec
16.13 Xentech
16.14 Company 13
16.15 Company 14 & More
*Financials would be provided on a best efforts basis for private companies
17. Patient Derived Xenograft/PDX Models Market - Appendix17.1 Abbreviations
17.2 Sources
18. Patient Derived Xenograft/PDX Models Market - Methodology
18.1 Research Methodology
18.1.1 Company Expert Interviews
18.1.2 Industry Databases
18.1.3 Associations
18.1.4 Company News
18.1.5 Company Annual Reports
18.1.6 Application Trends
18.1.7 New Products and Product database
18.1.8 Company Transcripts
18.1.9 R&D Trends
18.1.10 Key Opinion Leaders Interviews
18.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Patient Derived Xenograftmodels Market, By Type Market 2023-2030 ($M)1.1 Mouse Model Market 2023-2030 ($M) - Global Industry Research
1.2 Rat Model Market 2023-2030 ($M) - Global Industry Research
2.Global Nuclear Medicine Market, By Type Market 2023-2030 ($M)
3.Global Patient Derived Xenograftmodels Market, By Tumor Type Market 2023-2030 ($M)
3.1 Rhenium-186 Market 2023-2030 ($M) - Global Industry Research
3.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market 2023-2030 ($M) - Global Industry Research
3.3 Gastrointestinal Tumor Model Market 2023-2030 ($M) - Global Industry Research
3.4 Gynecological Tumor Model Market 2023-2030 ($M) - Global Industry Research
3.4.1 Lutetium-177 Market 2023-2030 ($M)
3.4.2 Alpha Emitter Market 2023-2030 ($M)
3.5 Respiratory Tumor Model Market 2023-2030 ($M) - Global Industry Research
3.6 Urological Tumor Model Market 2023-2030 ($M) - Global Industry Research
3.7 Hematological Tumor Model Market 2023-2030 ($M) - Global Industry Research
4.Global Patient Derived Xenograftmodels Market, By End User Market 2023-2030 ($M)
4.1 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Global Industry Research
4.2 Contract Research Organization Market 2023-2030 ($M) - Global Industry Research
4.3 Academic & Research Institution Market 2023-2030 ($M) - Global Industry Research
5.Global Patient Derived Xenograftmodels Market, By Type Market 2023-2030 (Volume/Units)
5.1 Mouse Model Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Rat Model Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Nuclear Medicine Market, By Type Market 2023-2030 (Volume/Units)
7.Global Patient Derived Xenograftmodels Market, By Tumor Type Market 2023-2030 (Volume/Units)
7.1 Rhenium-186 Market 2023-2030 (Volume/Units) - Global Industry Research
7.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market 2023-2030 (Volume/Units) - Global Industry Research
7.3 Gastrointestinal Tumor Model Market 2023-2030 (Volume/Units) - Global Industry Research
7.4 Gynecological Tumor Model Market 2023-2030 (Volume/Units) - Global Industry Research
7.4.1 Lutetium-177 Market 2023-2030 (Volume/Units)
7.4.2 Alpha Emitter Market 2023-2030 (Volume/Units)
7.5 Respiratory Tumor Model Market 2023-2030 (Volume/Units) - Global Industry Research
7.6 Urological Tumor Model Market 2023-2030 (Volume/Units) - Global Industry Research
7.7 Hematological Tumor Model Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Patient Derived Xenograftmodels Market, By End User Market 2023-2030 (Volume/Units)
8.1 Pharmaceutical & Biotechnology Company Market 2023-2030 (Volume/Units) - Global Industry Research
8.2 Contract Research Organization Market 2023-2030 (Volume/Units) - Global Industry Research
8.3 Academic & Research Institution Market 2023-2030 (Volume/Units) - Global Industry Research
9.North America Patient Derived Xenograftmodels Market, By Type Market 2023-2030 ($M)
9.1 Mouse Model Market 2023-2030 ($M) - Regional Industry Research
9.2 Rat Model Market 2023-2030 ($M) - Regional Industry Research
10.North America Nuclear Medicine Market, By Type Market 2023-2030 ($M)
11.North America Patient Derived Xenograftmodels Market, By Tumor Type Market 2023-2030 ($M)
11.1 Rhenium-186 Market 2023-2030 ($M) - Regional Industry Research
11.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
11.3 Gastrointestinal Tumor Model Market 2023-2030 ($M) - Regional Industry Research
11.4 Gynecological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
11.4.1 Lutetium-177 Market 2023-2030 ($M)
11.4.2 Alpha Emitter Market 2023-2030 ($M)
11.5 Respiratory Tumor Model Market 2023-2030 ($M) - Regional Industry Research
11.6 Urological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
11.7 Hematological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
12.North America Patient Derived Xenograftmodels Market, By End User Market 2023-2030 ($M)
12.1 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
12.2 Contract Research Organization Market 2023-2030 ($M) - Regional Industry Research
12.3 Academic & Research Institution Market 2023-2030 ($M) - Regional Industry Research
13.South America Patient Derived Xenograftmodels Market, By Type Market 2023-2030 ($M)
13.1 Mouse Model Market 2023-2030 ($M) - Regional Industry Research
13.2 Rat Model Market 2023-2030 ($M) - Regional Industry Research
14.South America Nuclear Medicine Market, By Type Market 2023-2030 ($M)
15.South America Patient Derived Xenograftmodels Market, By Tumor Type Market 2023-2030 ($M)
15.1 Rhenium-186 Market 2023-2030 ($M) - Regional Industry Research
15.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
15.3 Gastrointestinal Tumor Model Market 2023-2030 ($M) - Regional Industry Research
15.4 Gynecological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
15.4.1 Lutetium-177 Market 2023-2030 ($M)
15.4.2 Alpha Emitter Market 2023-2030 ($M)
15.5 Respiratory Tumor Model Market 2023-2030 ($M) - Regional Industry Research
15.6 Urological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
15.7 Hematological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
16.South America Patient Derived Xenograftmodels Market, By End User Market 2023-2030 ($M)
16.1 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
16.2 Contract Research Organization Market 2023-2030 ($M) - Regional Industry Research
16.3 Academic & Research Institution Market 2023-2030 ($M) - Regional Industry Research
17.Europe Patient Derived Xenograftmodels Market, By Type Market 2023-2030 ($M)
17.1 Mouse Model Market 2023-2030 ($M) - Regional Industry Research
17.2 Rat Model Market 2023-2030 ($M) - Regional Industry Research
18.Europe Nuclear Medicine Market, By Type Market 2023-2030 ($M)
19.Europe Patient Derived Xenograftmodels Market, By Tumor Type Market 2023-2030 ($M)
19.1 Rhenium-186 Market 2023-2030 ($M) - Regional Industry Research
19.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
19.3 Gastrointestinal Tumor Model Market 2023-2030 ($M) - Regional Industry Research
19.4 Gynecological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
19.4.1 Lutetium-177 Market 2023-2030 ($M)
19.4.2 Alpha Emitter Market 2023-2030 ($M)
19.5 Respiratory Tumor Model Market 2023-2030 ($M) - Regional Industry Research
19.6 Urological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
19.7 Hematological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
20.Europe Patient Derived Xenograftmodels Market, By End User Market 2023-2030 ($M)
20.1 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
20.2 Contract Research Organization Market 2023-2030 ($M) - Regional Industry Research
20.3 Academic & Research Institution Market 2023-2030 ($M) - Regional Industry Research
21.APAC Patient Derived Xenograftmodels Market, By Type Market 2023-2030 ($M)
21.1 Mouse Model Market 2023-2030 ($M) - Regional Industry Research
21.2 Rat Model Market 2023-2030 ($M) - Regional Industry Research
22.APAC Nuclear Medicine Market, By Type Market 2023-2030 ($M)
23.APAC Patient Derived Xenograftmodels Market, By Tumor Type Market 2023-2030 ($M)
23.1 Rhenium-186 Market 2023-2030 ($M) - Regional Industry Research
23.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
23.3 Gastrointestinal Tumor Model Market 2023-2030 ($M) - Regional Industry Research
23.4 Gynecological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
23.4.1 Lutetium-177 Market 2023-2030 ($M)
23.4.2 Alpha Emitter Market 2023-2030 ($M)
23.5 Respiratory Tumor Model Market 2023-2030 ($M) - Regional Industry Research
23.6 Urological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
23.7 Hematological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
24.APAC Patient Derived Xenograftmodels Market, By End User Market 2023-2030 ($M)
24.1 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
24.2 Contract Research Organization Market 2023-2030 ($M) - Regional Industry Research
24.3 Academic & Research Institution Market 2023-2030 ($M) - Regional Industry Research
25.MENA Patient Derived Xenograftmodels Market, By Type Market 2023-2030 ($M)
25.1 Mouse Model Market 2023-2030 ($M) - Regional Industry Research
25.2 Rat Model Market 2023-2030 ($M) - Regional Industry Research
26.MENA Nuclear Medicine Market, By Type Market 2023-2030 ($M)
27.MENA Patient Derived Xenograftmodels Market, By Tumor Type Market 2023-2030 ($M)
27.1 Rhenium-186 Market 2023-2030 ($M) - Regional Industry Research
27.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
27.3 Gastrointestinal Tumor Model Market 2023-2030 ($M) - Regional Industry Research
27.4 Gynecological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
27.4.1 Lutetium-177 Market 2023-2030 ($M)
27.4.2 Alpha Emitter Market 2023-2030 ($M)
27.5 Respiratory Tumor Model Market 2023-2030 ($M) - Regional Industry Research
27.6 Urological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
27.7 Hematological Tumor Model Market 2023-2030 ($M) - Regional Industry Research
28.MENA Patient Derived Xenograftmodels Market, By End User Market 2023-2030 ($M)
28.1 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
28.2 Contract Research Organization Market 2023-2030 ($M) - Regional Industry Research
28.3 Academic & Research Institution Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)2.Canada Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
3.Mexico Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
4.Brazil Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
5.Argentina Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
6.Peru Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
7.Colombia Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
8.Chile Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
9.Rest of South America Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
10.UK Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
11.Germany Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
12.France Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
13.Italy Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
14.Spain Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
15.Rest of Europe Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
16.China Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
17.India Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
18.Japan Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
19.South Korea Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
20.South Africa Patient Derived Xenograft/PDX Models Market Revenue, 2023-2030 ($M)
21.North America Patient Derived Xenograft/PDX Models By Application
22.South America Patient Derived Xenograft/PDX Models By Application
23.Europe Patient Derived Xenograft/PDX Models By Application
24.APAC Patient Derived Xenograft/PDX Models By Application
25.MENA Patient Derived Xenograft/PDX Models By Application
26.Crown Bioscience Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.The Jackson Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Champion Oncology, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Charles River Laboratory International, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Wuxi Apptec, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Oncodesign, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Horizon Discovery Group Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Pharmatest Service Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Hera Biolabs, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Epo Berlin-Buch Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Xentech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Urolead, Sales /Revenue, 2015-2018 ($Mn/$Bn)